333 related articles for article (PubMed ID: 20095945)
1. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
3. [Research of oral prodrugs: opportunities and challenges].
Cao F; Ping QN; Chen J
Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
[TBL] [Abstract][Full Text] [Related]
4. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
Asghar LF; Chandran S
J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
[TBL] [Abstract][Full Text] [Related]
5. Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis.
Lee Y; Kim H; Kim W; Yoon JH; Jeong SH; Jung Y
J Drug Target; 2012 Jul; 20(6):524-34. PubMed ID: 22632102
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
[TBL] [Abstract][Full Text] [Related]
7. Prodrug strategies in anticancer chemotherapy.
Kratz F; Müller IA; Ryppa C; Warnecke A
ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
[TBL] [Abstract][Full Text] [Related]
8. Do prodrugs deliver?
Smith DA
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
[TBL] [Abstract][Full Text] [Related]
9. Novel prospective in colon specific drug delivery system.
Bansal V; Malviya R; Malaviya T; Sharma PK
Polim Med; 2014; 44(2):109-18. PubMed ID: 24967782
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
[TBL] [Abstract][Full Text] [Related]
11. Strategies to improve oral drug bioavailability.
Gomez-Orellana I
Expert Opin Drug Deliv; 2005 May; 2(3):419-33. PubMed ID: 16296764
[TBL] [Abstract][Full Text] [Related]
12. Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach.
Philip AK; Dubey RK; Pathak K
J Pharm Pharmacol; 2008 May; 60(5):607-13. PubMed ID: 18416937
[TBL] [Abstract][Full Text] [Related]
13. Prodrug strategies to overcome poor water solubility.
Stella VJ; Nti-Addae KW
Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
[TBL] [Abstract][Full Text] [Related]
14. Colonic drug delivery: an updated review.
Shareef MA; Khar RK; Ahuja A; Ahmad FJ; Raghava S
AAPS PharmSci; 2003; 5(2):E17. PubMed ID: 12866944
[TBL] [Abstract][Full Text] [Related]
15. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
16. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
17. Orally active factor Xa inhibitors: investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy.
Uchida M; Okazaki K; Mukaiyama H; Isawa H; Kobayashi H; Shiohara H; Muranaka H; Kai Y; Kikuchi N; Takeuchi H; Yokoyama K; Tsuji E; Ozawa T; Hoyano Y; Koizumi T; Misawa K; Hara K; Nakano S; Murakami Y; Okuno H
Bioorg Med Chem Lett; 2008 Aug; 18(16):4682-7. PubMed ID: 18667303
[TBL] [Abstract][Full Text] [Related]
18. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
19. Targeting drugs to the colon: delivery systems for oral administration.
Ashford M; Fell JT
J Drug Target; 1994; 2(3):241-57. PubMed ID: 7812693
[TBL] [Abstract][Full Text] [Related]
20. Colonic drug targeting.
Kinget R; Kalala W; Vervoort L; van den Mooter G
J Drug Target; 1998; 6(2):129-49. PubMed ID: 9886237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
